synthetic peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-11-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
=== Auto-ponderomotive guide === An auto-ponderomotive guide is an electrostatic counterpart to a Paul trap. The electron beam is directed into an area of segmented electrodes with alternating negative and positive static voltages placed at half a periodicity
=== Recreational use === It was said in the mid-1970s that use of nutmeg for recreational purposes was almost exclusively confined to the United States. It was said to be sought as an alternative to other preferred hallucinogens such as LSD and cannabis. The drug has frequently been used by incarcerated people in prisons. This has led to availability of nutmeg in prison kitchens being restricted.
Action Game – Grand Theft Auto: Vice City Adventure Game – The Legend of Zelda: The Wind Waker Animation or Intro – Soulcalibur II (Jame Chung Edition) Children's Game – EyeToy: Play Design – Grand Theft Auto: Vice City Game Boy Advance Game – Advance Wars 2: Black Hole Rising Game on Any Platform – The Year's Best Game – Call of Duty GameCube – Metroid Prime Mobile Game – Tony Hawk's Pro Skater Multiplayer – Battlefield 1942 Original Music – Harry Potter and the Chamber of Secrets PC – Grand Theft Auto: Vice City PS2 – Grand Theft Auto: Vice City Racing – Project Gotham Racing 2 Sound – Grand Theft Auto: Vice City Sports – FIFA Football 2004 Strategy – Advance Wars 2: Black Hole Rising Sunday Times Reader Award for Games – Grand Theft Auto: Vice City Technical Achievement – EyeToy: Play Xbox – Star Wars: Knights of the Old Republic Special Award (Games) – Chris Deering
=== Chronic urticaria === Chronic urticaria (CU) is characterized by wheal and flare symptoms of the skin lasting more than six weeks at a time. Symptoms of CU appear to be caused by the degranulation of mast cells in skin. CU has two subtypes: chronic inducible urticaria (CIndU, identifiable triggers) and chronic spontaneous urticaria (CSU, unpredictable triggers). In type I CSU, IgE autoantibodies are directed against self-antigens. In type IIb CSU, autoantibodies are directed against IgE or FcεRI.
Sources: en.wikipedia.org
The initial product of that enzyme is the peracid of ureidoacrylic acid, to which it spontaneously converts. Pyrimidine oxygenase can also use thymine as a substrate and in that case its product is (Z)-2-methylureidoacrylic acid:
Epidurals can provide temporary relief but are not generally recommended as they can cause cysts to enlarge. Extraction of fluid can provide limited or no relief depending on rate the cysts refill and the need to repeat the procedure. Removal of the cyst results in irreversible damage to the intersecting spinal nerve. Although fibrin-glue therapy initially had been thought to be a promising therapy in the treatment of these cysts, there have been multiple problems associated with the fibrin glue therapy including seepage of fibrin. It is no longer recommended for use at present by the Health Department in some countries and neurosurgeons previously performing the procedures. Nevertheless, all types of surgical treatment pose common risks, including neurological deficits, infection and inflammation, spinal headache, urinary disturbances, and leakage of cerebrospinal fluids.
==== Triptans (serotonin 5-HT1B and 5-HT1D receptor agonists) ==== Almotriptan (Almogran; Axert; LAS-31416) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [119] Eletriptan (Relert; Relpax; UK-116044) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine, menstrual migraine [120] Frovatriptan (Allegro; Auradol; EN-3266; Frova; Isimig; Migard; Pitunal; Rilamig; SB-209509; SB-209509AX; VML-251) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [121] Naratriptan (Amerge; GR-85548; GR-85548A; Naramig; SMP-948) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [122] Rizatriptan (L-705126; Maxalt; MK-0462; MK-462) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [123] Rizatriptan oral film (INT-0008; RHB-103; Rizafilm; VersaFilm; RizaPort) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [124] Sumatriptan (Imigran Nasal Spray; Imitrex Nasal Spray) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [125] Zolmitriptan (311-C90; 311C; AscoTop; BW-311C90; Zomig; Zomigon) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – cluster headache, menstrual migraine, migraine [126] Zolmitriptan oral dispersible film (zolmitriptan ODF; Zolmitriptan PharmaFilm; Zolmitriptan RapidFilm; Zolmitriptan Renantos Schmelzfilm) – serotonin 5-HT1B and 5-HT1D receptor agonist and triptan – migraine [127]
==== By activase ==== The removal of the inhibitory RuBP, CA1P, and the other inhibitory substrate analogs by activase requires the consumption of ATP. This reaction is inhibited by the presence of ADP, and, thus, activase activity depends on the ratio of these compounds in the chloroplast stroma. Furthermore, in most plants, the sensitivity of activase to the ratio of ATP/ADP is modified by the stromal reduction/oxidation (redox) state through another small regulatory protein, thioredoxin. In this manner, the activity of activase and the activation state of RuBisCO can be modulated in response to light intensity and, thus, the rate of formation of the ribulose 1,5-bisphosphate substrate.
=== 4 March === Ukrainian forces reportedly began their withdrawal from Bakhmut and reports stated that many civilians fled from the city. Rheinmetall, a German military vehicle and weapons manufacturing company, is reported to be negotiating with the government of Ukraine about the possibility of building a tank factory in Ukraine. The proposed factory would cost about 200 million euros and be capable of producing up to 400 Panther KF51 tanks per year. Armin Papperger, the CEO, reportedly argues that Ukraine would need about 600 to 800 new tanks to win the war, which is more than the 300 existing tanks that Germany could supply them with. The Ukrainian Defence Minister, Oleksiy Reznikov, wrote a letter to the European Union asking for 250,000 155mm shells per month. Ukrainian forces use approximately 110,000 155mm shells per month. He claimed that Ukrainian forces were only firing a fifth of what they could due to shortages. The Ukrainian hope is to use "594,000" shells per month. NATO is considering establishing factories in Eastern Europe to increase production of Soviet era ammunition.
Sources: en.wikipedia.org
Scarification involves scratching, etching, burning/branding, or superficially cutting designs, pictures, or words into the skin as a permanent body modification or body art. The body modification can take roughly 6–12 months to heal. In the process of body scarification, scars are purposely formed by cutting or branding the skin by various methods (sometimes using further sequential aggravating wound-healing methods at timed intervals, like irritation). Scarification is sometimes called cicatrization.
=== Bleeding lance === The bleeding lance has taken numerous forms throughout the Arthurian literature. In the earlier appearances of the lance, it is not represented as a Christian symbol, but transforms into one over time. In its early appearances in Perceval and Parzival, the lance is described as having "barbaric properties" which are difficult to associate with Christian influence. Chrétien describes his lance with "marvelous destructive powers", which holds a closer connection to the malignant weapons of Celtic origin. In Chrétien's Perceval, the lance is a dark and almost evil motif and also seems to overshadow the Grail, which, were this a Christian story, would be rather odd. Wolfram's tale also treated the lance in a similar dark manner. In Parzival, the lance is "poisonous" which contrasts sharply with the general trend of healing Christian themes. This lance is plunged into the Fisher King's wound at different times to continue his pain, as punishment for having sought forbidden love. This lance is considered significant because it is most often associated directly with the wound of the Fisher King, which is demonstrated both in Chrétien's and Eschenbach's versions of the tale. The more recent writings have the lance presented in the Fisher King's castle with Christian theology. More specifically, it is supposed to be the lance that pierced Jesus Christ while on the cross. This is seen in Malory's Le Morte d'Arthur. In Malory's version, the Fisher King is healed with the blood from the lance, signifying it as a good, holy, Christian object.
Police Scotland arrest Scotland's former First Minister, Nicola Sturgeon, as part of their ongoing investigation into the SNP's finances. She is subsequently released without charge. 12 June Following a period of hot weather, thunderstorms and torrential rain bring flash flooding to parts of the UK. A mother-of-three is sentenced to 28 months in prison for inducing an abortion at home during 2020 with medication while she was 32–34 weeks pregnant. The medication was obtained following a remote consultation at which the woman misled doctors over the advancement of her pregnancy. 13 June 2023 Nottingham attacks: A major incident is declared in Nottingham, with much of the city centre cordoned off, following a vehicle-ramming and knife attack. A 31-year-old man is arrested on suspicion of multiple murders, following the deaths of three people including two university students, while three others are hospitalised. The first day of a public inquiry into the COVID-19 pandemic begins in central London. The inquiry's lead lawyer says "very little thought" was given about the impact of a national lockdown and that Brexit planning may have occupied too much of the government's time and resources, while a counsel for the Covid-19 Bereaved Families for Justice accuses the authorities of being "complacent". A heatwave is declared in several parts of the UK as temperatures reach 30 °C, and after exceeding 25 °C for three consecutive days; the UK's heat-health alert is also extended.
=== Expression proteomics === Expression proteomics includes the analysis of protein expression at a larger scale. It helps identify main proteins in a particular sample, and those proteins differentially expressed in related samples—such as diseased vs. healthy tissue. If a protein is found only in a diseased sample then it can be a useful drug target or diagnostic marker. Proteins with the same or similar expression profiles may also be functionally related. There are technologies such as 2D-PAGE and mass spectrometry that are used in expression proteomics.
== Bibliography == J. Samuel Walker (November 1, 2000). Permissible Dose: A History of Radiation Protection in the Twentieth Century. University of California Press. ISBN 978-0-520-92484-0. Limited preview in Google Books. K. N. Govinda Rajan (July 28, 2017). Radiation Safety in Radiation Oncology. CRC Press. ISBN 978-1-4987-6226-7. Limited preview in Google Books. Strahlengefahrdung und Strahlenschutz / Radiation Exposure and Radiation Protection. Springer-Publisher. March 13, 2013. ISBN 978-3-642-82229-2. Limited preview in Google Books J. Samuel Walker (April 2001). Short History of Nuclear Regulation, 1946–1999. DIANE Publishing. ISBN 978-0-7567-0929-7.Limited preview in Google Books. Ashley W. Oughterson, Shields Warren: Medical Effects of the Atomic Bomb in Japan. Volume VIII.8 aus der National Nuclear Energy Series zum Manhattan Project, McGraw-Hill Book Company, 1956. Carl Voegtlin, Harold C. Hodge: Pharmacology and Toxicology of Uranium Compounds. Volume VI.1, Part I and Part II (with a Section on the Pharmacology and Toxicology of Fluorine and Hydrogen Fluoride) from the National Nuclear Energy Series to the Manhattan Project, McGraw-Hill Book Company, 1949. Henry DeWolf Smyth (written on the request of Maj. Gen. L. R. Groves): Atomic Energy for Military Purposes. The official report on the development of the atomic bomb under the auspices of the United States Government, 1940–1945. Princeton University Press, 1946. James E. Grindler (Argonne National Laboratory): The Radiochemistry of Uranium.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.